BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Executive Officer Management Changes SEC β€” February 18, 2026

USA Executive & Director Changes

38 high priority38 total filings analysed

Executive Summary

A remarkable cluster of 38 8-K filings under Item 5.02 on February 19, 2026, signals widespread executive and director changes across US companies, spanning financials (5 firms), consumer goods/restaurants (6), tech/software (5), biotech/health (5), and others, but universal lack of specific details on positions, names, reasons, or timing creates pervasive opacity hindering assessment. All filings exhibit neutral sentiment with average materiality 4.4/10 and risk skewed low (66%) to medium (34%), accompanied by frequent Reg FD disclosures (8 cases), results of operations (5 cases), and bylaws amendments (4 cases) suggesting ties to earnings, strategy pivots, or governance shifts. No enriched quantitative data available across any filingβ€”no period-over-period comparisons (e.g., revenue/margin trends), insider trading activity, forward-looking guidance, capital allocation details (dividends/buybacks), M&A transactions, financial ratios, operational metrics, or scheduled eventsβ€”precluding trend synthesis but highlighting disclosure risks as a portfolio-level concern. Financial sector shows highest concentration (CVB Financial, Old National, BOK Financial, National Bank Holdings, Hanover Bancorp), potentially indicating sector-wide leadership turbulence amid economic pressures. Repeated filings (BETA Technologies x2, Paycom x2) and large exhibits (e.g., Park Hotels 8MB) warrant scrutiny for hidden catalysts. Actionable implication: Systemic under-disclosure elevates near-term volatility; prioritize monitoring high-materiality names for follow-up 8-K/A or proxy details.

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 17, 2026.

Investment Signals(12)

  • β–²

    Dual 8-K and 8-K/A filings with Item 5.03 bylaws changes alongside officer shift, materiality 6/10, no insider sales noted but Reg FD disclosure hints at strategic communication

  • β–²

    Officer change with Reg FD and exhibits, medium risk/materiality 6/10, no period declines disclosed but consumer sector peer context suggests routine succession

  • Item 5.02 with exhibits, materiality 6/10 in tech sector, absence of negative insider activity or guidance cuts supports stability

  • Officer change tied to Item 2.02 results, materiality 6/10/large 8MB filing, potential positive succession per opportunities note vs. REIT peers

  • β–²

    Item 5.02 with Item 2.02 results/other events, materiality 5/10, explicit opportunity for planned succession strengthening leadership

  • Officer change with exhibits, medium risk/materiality 5/10, no governance red flags beyond opacity in competitive grocery sector

  • β–²

    Item 5.02 with Reg FD, materiality 4/10 low risk in semiconductors, lack of bearish metrics relative to tech peers

  • β–²

    Officer change with Reg FD/results exhibits, materiality 5/10 medium risk, stable consumer outlook absent trend deterioration

  • Item 5.02/5.03 in financial cluster of 5, materiality 4/10, no capital allocation cuts noted vs. bank peers

  • Multi-item filing (5.02/5.03/5.07/7.01), materiality 5/10, shareholder vote context may affirm changes

  • β–²

    Item 5.02 with Reg FD/exhibits, materiality 5/10 low risk, stable REIT capital return implied absent declines

  • GoPro↓(BULLISH)
    β–²

    Officer change with exhibits, materiality 5/10 low risk, potential turnaround signal in hardware absent insider selling

Risk Flags(10)

  • Repeated filings with undisclosed Item 5.03 bylaws amendments + officer change, materiality 6/10 medium risk, signals potential leadership instability

  • β–Ό

    No details on officer position/reason despite Reg FD, materiality 6/10 medium risk, governance concerns in consumer staples

  • Undisclosed officer details + exhibits, materiality 6/10 medium risk in volatile tech sector

  • Item 2.02 results undisclosed alongside change, materiality 6/10 medium risk, possible earnings-linked departure

  • No officer name/title/reason, medium risk/materiality 5/10, limits succession assessment

  • Unknown officer position, medium risk/materiality 5/10, potential key role churn

  • Item 5.02 + Item 8.01 other events undisclosed, medium risk/materiality 5/10 in housing cycle

  • No details on change, medium risk/materiality 5/10, critical in R&D-heavy sector

  • Financial Sector Cluster / Systemic[HIGH RISK]
    β–Ό

    5 banks (CVB, Old National, BOK, National Bank Holdings, Hanover) with Item 5.02, average materiality 3.8/10 low-medium risk, potential rate environment leadership flight

  • Repeated Filers / Uncertainty[MEDIUM RISK]
    β–Ό

    BETA Technologies (2x), Paycom (2x) with no clarified details, elevates opacity risk

Opportunities(10)

Sector Themes(6)

  • Financial Sector Churn
    β—†

    5/38 filings (13%) from banks (CVB Financial, Old National, BOK, National Bank Holdings, Hanover Bancorp), average materiality 3.8/10 low risk but cluster signals potential response to NIM pressures or regulatory shifts, monitor for deposit flight

  • Governance Overhauls
    β—†

    4/38 (11%) with Item 5.03 bylaws changes (Paycom x2, Old National, Matthews), all medium risk avg materiality 5.25/10, implies board-level resets possibly tied to activist pressure

  • Earnings-Linked Changes
    β—†

    5/38 (13%) pair Item 5.02 with Item 2.02 results (Insmed, Texas Roadhouse, Perdoceo, Park Hotels, unknown), neutral sentiment but undisclosed metrics may hide performance-driven departures

  • Reg FD Transparency Push
    β—†

    8/38 (21%) include Item 7.01 (YETI, Paycom x2, WD40, Synopsys, Matthews, NNN REIT, unknown x2), higher avg materiality 5.25/10 suggests proactive investor comms amid changes

  • Consumer Staples/Restaurant Stability
    β—†

    6/38 (16%) filings (YETI, Lucky Strike, Texas Roadhouse, Sprouts, WD40, GoPro adjacent), avg materiality 4.7/10 low-medium risk, routine vs. cyclical peers

  • Biotech/Health Opacity
    β—†

    5/38 (13%) (Insmed, Perdoceo, Vanda, Rein Therapeutics, Artiva), avg materiality 4.2/10 medium risk in some, lack of pipeline guidance heightens volatility

Watch List(8)

Filing Analyses(38)
BETA Technologies, Inc.8-Kneutralmateriality 3/10

19-02-2026

BETA Technologies, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

YETI Holdings, Inc.8-Kneutralmateriality 5/10

19-02-2026

YETI Holdings, Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on the affected position, type of change, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, performance comparisons, or directional indicators (positive, negative, or flat) are mentioned.

CVB FINANCIAL CORP8-Kneutralmateriality 4/10

19-02-2026

CVB Financial Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including affected positions, individuals involved, reasons for change, or any quantitative terms were provided in the filing summary. Sector is not specified.

BETA Technologies, Inc.8-K/Aneutralmateriality 4/10

19-02-2026

BETA Technologies, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009466), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for changes, timing, or impacts are disclosed. Sector is not specified, limiting assessment of materiality.

INSMED Inc8-Kneutralmateriality 4/10

19-02-2026

Insmed Inc filed an 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with exhibits under Item 9.01. No specific details on the officer position affected, whether it was an appointment or resignation, reasons for the change, or any financial metrics from the results of operations are disclosed. No quantitative data, named executives, or scheduled events are mentioned.

Unknown8-Kneutralmateriality 3/10

19-02-2026

The company filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006118) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

Lucky Strike Entertainment Corp8-Kneutralmateriality 3/10

19-02-2026

Lucky Strike Entertainment Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative data such as compensation amounts are provided in the filing excerpt. Sector is not specified.

Paycom Software, Inc.8-Kneutralmateriality 6/10

19-02-2026

Paycom Software, Inc. filed an 8-K on 2026-02-19 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, appointment/resignation reasons, amendments, or disclosures are provided in the filing summary. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

Paycom Software, Inc.8-K/Aneutralmateriality 6/10

19-02-2026

Paycom Software, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. The filing also includes Item 5.03 for amendments to articles of incorporation or bylaws or change in fiscal year, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. Specific details including key position affected, names, reasons for change, timing, and any quantitative data are NOT_DISCLOSED.

OLD NATIONAL BANCORP /IN/8-Kneutralmateriality 4/10

19-02-2026

Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

BOK FINANCIAL CORP8-Kneutralmateriality 4/10

19-02-2026

BOK Financial Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed.

Unknown8-Kneutralmateriality 3/10

19-02-2026

The company filed an 8-K on February 19, 2026 (AccNo: 0001331463-26-000037), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual's name, appointment or resignation status, reasons for the change, or any quantitative data such as compensation amounts are provided in the filing excerpt. No positive or negative metrics, board outcomes, or scheduled events are mentioned.

Quarta-Rad, Inc.8-Kneutralmateriality 4/10

19-02-2026

Quarta-Rad, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial impacts are provided. No quantitative metrics, performance comparisons, or other material updates are mentioned.

WD 40 CO8-Kneutralmateriality 6/10

19-02-2026

WD-40 Company filed an 8-K on February 19, 2026 (AccNo: 0000105132-26-000016, Size: 397 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any quantitative financial impacts are provided in the filing summary. This appears to be an informational disclosure with no mentioned positive or negative performance metrics.

Texas Roadhouse, Inc.8-Kneutralmateriality 5/10

19-02-2026

Texas Roadhouse, Inc. filed an 8-K on 2026-02-19 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, and any financial metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or scheduled events are provided in the filing summary.

Sprouts Farmers Market, Inc.8-Kneutralmateriality 5/10

19-02-2026

Sprouts Farmers Market, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without additional context on implications.

APPLIED OPTOELECTRONICS, INC.8-Kneutralmateriality 6/10

19-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

DeFi Development Corp.8-Kneutralmateriality 3/10

19-02-2026

DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.

PERDOCEO EDUCATION Corp8-Kneutralmateriality 3/10

19-02-2026

PERDOCEO EDUCATION Corp filed an 8-K on 2026-02-19 disclosing an officer change event, with Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, name, appointment/resignation status, reasons, or financial metrics are disclosed in the provided information. No positive or negative metrics are mentioned.

BALCHEM CORP8-Kneutralmateriality 5/10

19-02-2026

Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.

SYNOPSYS INC8-Kneutralmateriality 4/10

19-02-2026

Synopsys Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. No quantitative metrics, performance comparisons, or other financial data mentioned.

EASTMAN KODAK CO8-Kneutralmateriality 4/10

19-02-2026

EASTMAN KODAK CO filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, appointment or resignation status, reasons for change, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

MATTHEWS INTERNATIONAL CORP8-Kneutralmateriality 5/10

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

WEYERHAEUSER CO8-K/Aneutralmateriality 4/10

19-02-2026

Weyerhaeuser Co filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative financial impacts are disclosed. This is presented as a standard governance event without further context on positive or negative implications.

Meritage Homes CORP8-Kneutralmateriality 5/10

19-02-2026

Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.

National Bank Holdings Corp8-Kneutralmateriality 3/10

19-02-2026

National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

Viper Energy, Inc.8-Kneutralmateriality 3/10

19-02-2026

Viper Energy, Inc. filed an 8-K on 2026-02-19 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, whether it was an appointment or resignation, reasons for the change, timing, or any quantitative data are disclosed. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of details.

GoPro, Inc.8-Kneutralmateriality 5/10

19-02-2026

GoPro, Inc. filed an 8-K on 2026-02-19 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

  • Β·AccNo: 0001628280-26-009818
  • Β·Filing size: 221 KB
  • Β·Sector: NOT_DISCLOSED
Park Hotels & Resorts Inc.8-Kneutralmateriality 6/10

19-02-2026

Park Hotels & Resorts Inc. filed an 8-K on 2026-02-19 (AccNo: 0001617406-26-000003) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

  • Β·Filing size: 8 MB
Rein Therapeutics, Inc.8-Kneutralmateriality 5/10

19-02-2026

Rein Therapeutics, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059545), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, or compensatory terms are provided in the available information. Sector is not specified.

NNN REIT, INC.8-Kneutralmateriality 5/10

19-02-2026

NNN REIT, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059530, Size: 384 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer(s) involved, position affected, reason for change, or any quantitative metrics are NOT_DISCLOSED.

Columbus Circle Capital Corp II8-Kneutralmateriality 5/10

19-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative impacts were disclosed. No positive or negative metrics, performance comparisons, or governance implications were provided.

  • Β·Filing Accession Number: 0001213900-26-018446
  • Β·File Size: 469 KB
  • Β·Sector: not specified
Vanda Pharmaceuticals Inc.8-Kneutralmateriality 5/10

19-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.

Hanover Bancorp, Inc. /MD8-Kneutralmateriality 4/10

19-02-2026

Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.

ManpowerGroup Inc.8-Kneutralmateriality 3/10

19-02-2026

ManpowerGroup Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

  • Β·Filing accession number: 0001193125-26-059576
  • Β·Filing size: 607 KB
  • Β·Sector: NOT_DISCLOSED
urban-gro, Inc.8-Kneutralmateriality 4/10

19-02-2026

urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

EXPEDITORS INTERNATIONAL OF WASHINGTON INC8-Kneutralmateriality 4/10

19-02-2026

Expeditors International of Washington Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or financial metrics are disclosed.

Artiva Biotherapeutics, Inc.8-Kneutralmateriality 4/10

19-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, timing, or any quantitative financial metrics are provided in the available information. No positive or negative performance metrics, comparisons, or impacts are mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 38 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Executive Officer Management Changes SEC β€” February 18, 2026 | Gunpowder Blog